Also trades as: 0Y6X.L (LSE) · $vol 1M · 2M6.DE (XETRA) · $vol 0M

$93.95

-0.84 (-0.89%)

Weekly Expected Move ±4.3%

$87 $91 $95 $99 $104

NYSE · Healthcare · Medical - Devices · Tech Score Buy · Power 80 · $120.2B mcap · 1.28B float · 1.11% daily turnover · Short 48% of daily vol

Credit Risk of going bust: lower than 81% of companies Debt: 19.0% of company value Bonds: $175.5M held by 166 funds, 54 bp over Treasuries → details ▾

If the stock fell to about $1.30 (down 99%), Medtronic Plc would be worth roughly what it owes.
Total debt $28.15B against a stock market value of $120.18B.
Distance to default 10.00 (Merton model): prices to 2026-10-27, balance sheet 2026-07-31, debt counted $15.34B (short-term plus half of long-term), stock volatility 24.6%; Altman Z'' 3.81. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue

$36.4B +8.4% ▲

5Y CAGR: +3.8%

Gross Profit

$23.6B +7.9% ▲

5Y CAGR: +3.8%

Operating Income

$6.5B +8.6% ▲

5Y CAGR: +7.6%

Net Income

$4.8B +3.0% ▲

5Y CAGR: +5.9%

EPS (Diluted)

$3.73 +3.3% ▲

5Y CAGR: +7.0%

EBITDA

$9.8B +6.4% ▲

5Y CAGR: +5.5%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$31.7B	$31.2B	$32.4B	$33.5B	$36.4B
YoY Growth	+5.2%	-1.4%	+3.6%	+3.6%	+8.4%
Cost of Revenue	$10.1B	$10.7B	$11.2B	$11.6B	$12.7B
Gross Profit	$21.5B	$20.5B	$21.1B	$21.9B	$23.6B
Gross Margin	68.0%	65.7%	65.3%	65.3%	65.0%
R&D Expenses	$2.7B	$2.7B	$2.7B	$2.7B	$2.9B
SG&A Expenses	$10.3B	$10.4B	$10.7B	$10.8B	$11.8B
Operating Expenses	$15.8B	$15.0B	$16.0B	$15.9B	$17.2B
Operating Income	$5.8B	$5.5B	$5.1B	$6.0B	$6.5B
Operating Margin	18.2%	17.6%	15.9%	17.8%	17.8%
Interest Expense	$553M	$636M	$719M	$729M	$715M
Income Before Tax	$5.5B	$5.4B	$4.8B	$5.6B	$6.1B
Tax Expense	$456M	$1.6B	$1.1B	$936M	$1.3B
Net Income	$5.0B	$3.8B	$3.7B	$4.7B	$4.8B
Net Margin	15.9%	12.0%	11.4%	13.9%	13.2%
EPS (Diluted)	$3.73	$2.82	$2.76	$3.61	$3.73
EBITDA	$8.8B	$8.7B	$8.2B	$9.2B	$9.8B
Shares Outstanding	1.35B	1.33B	1.33B	1.29B	1.29B

Line Item	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4	FY2027 Q1
Revenue	$8.4B	$8.3B	$8.9B	$8.6B	$9.0B	$9.0B	$9.8B	$9.8B
Cost of Revenue	$2.9B	$2.8B	$3.1B	$3.6B	$3.6B	$3.2B	$2.4B	$3.4B
Gross Profit	$5.5B	$5.5B	$5.8B	$4.9B	$5.4B	$5.9B	$7.4B	$6.3B
Gross Margin	64.9%	66.5%	64.7%	57.7%	60.3%	64.9%	75.9%	65.0%
R&D Expenses	$697M	$675M	$684M	$726M	$754M	$722M	$671M	$771M
SG&A Expenses	$2.8B	$2.7B	$2.7B	$2.8B	$3.0B	$3.0B	$3.1B	$3.2B
Operating Expenses	$3.9B	$3.9B	$4.3B	$3.5B	$3.7B	$4.1B	$5.9B	$4.6B
Operating Income	$1.6B	$1.6B	$1.4B	$1.4B	$1.7B	$1.8B	$1.6B	$1.8B
Operating Margin	19.0%	19.9%	16.1%	16.8%	18.8%	19.7%	15.9%	18.1%
Interest Expense	$209M	$179M	$174M	$176M	$181M	$181M	$177M	$186M
Income Before Tax	$1.6B	$1.5B	$1.3B	$1.3B	$1.6B	$1.4B	$1.8B	$1.8B
Tax Expense	$281M	$237M	$199M	$255M	$215M	$254M	$575M	$289M
Net Income	$1.3B	$1.3B	$1.1B	$1.0B	$1.4B	$1.1B	$1.2B	$1.5B
Net Margin	15.1%	15.6%	11.8%	12.1%	15.3%	12.7%	12.7%	15.1%
EPS (Diluted)	$0.99	$1.01	$0.82	$0.81	$1.07	$0.89	$0.96	$1.14
EBITDA	$2.4B	$2.4B	$2.3B	$2.2B	$2.5B	$2.3B	$2.6B	$2.7B
Shares Outstanding	1.29B	1.29B	1.29B	1.29B	1.29B	1.29B	1.29B	1.29B

MDT NYSE